DRUG-INDUCED DEMENTIA - INCIDENCE, MANAGEMENT AND PREVENTION

被引：50

作者：

STARR, JM ^{[1
]}

WHALLEY, LJ ^{[1
]}

机构：

[1] HAMMERSMITH HOSP,DIV GERIATR MED,LONDON W12 0HS,ENGLAND

来源：

DRUG SAFETY | 1994年 / 11卷 / 05期

关键词：

D O I：

10.2165/00002018-199411050-00003

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Drugs are a frequently cited cause of dementia. There is a paucity of data regarding the incidence of drug-induced dementia, but it has been estimated that over 10% of patients attending memory clinics have iatrogenic disease. Drugs may impair cognition indirectly via metabolic effects, such as hypoglycaemia, by alterations of immunological factors within the CNS, and by actions that interfere with synaptic transmission. Classes of drugs most frequently responsible are the benzodiazepines, antihypertensives and drugs with anticholinergic properties. Each of these classes is likely to produce a different pattern of neuropsychological deficits. Prevention of drug-induced dementia will be aided by: (i) minimising the number of drugs prescribed; (ii) using shorter-acting preparations; (iii) avoiding agents that cross the blood-brain barrier where possible; (iv) evaluating renal and hepatic function regularly; and (v) briefly assessing cognitive function before treatment.

引用

页码：310 / 317

页数：8

共 37 条

[21]

Wolfman A., Macara I.G., Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts, Nature, 325, (1987)

[22]

Parker P.J., Stabel S., Waterfield M.D., Purification to homogeneity of protein kinase C from bovine brain identity with the phorbol ester receptor, EMBO J, 3, (1984)

[23]

Greenberg M.E., Ziff E.B., Stimulation of 3T3 cells induces transcription of the c- fos proto-oncogene, Nature, 311, (1984)

[24]

Berg J.M., Potential metal-binding domains in nucleic acid binding proteins, Science, 232, (1986)

[25]

Cambier J.C., Newell M.K., Justement L.B., Et al., Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes, Nature, 327, (1987)

[26]

Lindsay R.M., Wiegand S.J., Altar C.A., Et al., Neurotrophic factors: from molecule to man, Trends Neurosci, 17, (1994)

[27]

Denicoff K.D., Rubinow D.R., Papa M.Z., Et al., The neuropsychiatrie effects of treatment with interleukin-2 and lymphocyte-activated killer cells, Ann Intern Med, 107, pp. 293-300, (1987)

[28]

Bertoli M., Romagnoli G.F., Margreiter R., Irreversible dementia following ciclosporin therapy in a renal transplant patient, Nephron, 49, (1988)

[29]

Meriky O., Reider-Groswasser I., Inbar M., Et al., Interferonrelated mental deterioration and behavioral changes in patients with renal cell carcinoma, Eur J Cancer, 26, pp. 596-600, (1990)

[30]

Bartus R.T., Deans R.L., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217, (1982)

← 1 2 3 4 →